共 50 条
- [4] Therapeutic Drug Monitoring of the Biosimilar SB2 (RENFLEXIS™, Infliximab-abda) Using LabCorp Infliximab Assays for Drug Level and Anti-drug Antibodies [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S25 - S25
- [7] Evaluation of pharmacokinetic profiles of SB2 as a biosimilar of reference infliximab [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S277 - S278
- [8] Therapeutic drug monitoring countering the effect of anti-infliximab antibodies [J]. LANCET RHEUMATOLOGY, 2024, 6 (04): : e193 - e194
- [9] The new biosimilar of infliximab SB2 can be quantified by IFX-optimised therapeutic drug monitoring assays [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S216 - S216
- [10] Development and evaluation of i-TRACKER infliximab and i-TRACKER anti-Infliximab kits: fast and innovative chemiluminescent assays for the monitoring of patients treated with infliximab [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S563 - S563